It is interesting to highlight that the only licensed vaccine against malaria, Mosquirix, is a recombinant vaccine that co-expressed a fraction of CSP and the hepatitis B surface antigen in a yeast-expression system, assembled into virus-like particles [129,130]. The gene discussed is DNAJC5; the disease is malaria.